Erectile dysfunction drugs and risk of anterior ischaemic optic neuropathy: Casual or causal association?

British Journal of Ophthalmology

Volumn 91, Issue 11, 2007, Pages 1551-1555

  Danesh Meyer, Helen V ^a   Levin, Leonard A ^b,c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL; VARDENAFIL;

ADULT; AGED; CLINICAL ARTICLE; DISEASE ASSOCIATION; ERECTILE DYSFUNCTION; HUMAN; ISCHEMIC OPTIC NEUROPATHY; MANAGED CARE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEXUAL DYSFUNCTION; VISUAL IMPAIRMENT;

3',5'-CYCLIC-GMP PHOSPHODIESTERASES; ADULT; AGED; EPIDEMIOLOGIC METHODS; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; OPTIC NEUROPATHY, ISCHEMIC; PHOSPHODIESTERASE INHIBITORS; PRODUCT SURVEILLANCE, POSTMARKETING; VASODILATOR AGENTS;

EID: 35748944904     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.125880     Document Type: Review

References (38)

1. Fink HA, MacDonald R, Rutks IR, et al. Sildenafil for male erectile dysfunction. Arch Intern Med 2002;162:1349-60.
2. Konstontinos H, Dimitrios H. Phosphodiesterase type 5 inhibitors: the day after. Eur Urol 2007;51:75-89.
3. Health Canada. Association of the erectile dysfunction medications Cialis (tadalafil), Levitra (vardenafil hydrochloride) and Viagra (sildenafil citrate) with visual problems (Dear Health Care Professional letter). Ottawa: Health Canada, 2006 June 19. Available: www.hc-sc.gc.ca/dhp-mps/medeff/ advisories-avis/ prof/2006/cialis_levitra_viagra_hpc-cps_e.html (accessed 2006 Jul 21).
4. Fraunfelder FW, Fraundfelder FT. Scientific challenges in postmarketing surveillance of ocular adverse drug reactions. Am J Ophthalmol 2007;143:145-9.
5. Kloner RA, Zusman RM. Cardiovascular effects of sildenafil citrate and recommendations for its use. Am J Cardiol 1999;84:11-17N.
6. Strom BL. Sample size considerations for pharmacoepidemiology studies. In: Strom BL, eds. Pharmacoepidemiology, 4th edition.Chichester: John Wiley & Sons, 2005:29-36.
7. Gorkin L, Hvidsten K, Sobel RE, et al. Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy, Int J Clin Pract 2006;60:500-3.
8. Morales A, Gingel C, Collins M, et al. Clinical safety of oral sildenafi citrate in the treatment of erectile dysfunction, Int J Impotence Res 1998;10:69-74.
9. Cheitlin MD, Hutter AM, Brindis RG, et al. Use of sildenafil (Viagra) in patients with cardiovascular disease. J Am Col Cardiol 1999;33:273-82.
10. Hennessy S. Disproportionality analyses of spontaneous reports. Pharmacoepidemiol Drug Saf 2004;13:503-4.
11. Gandhi JS. Sildenafil-associated NAION. Ophthalmology 2003;110:1860-1.
12. Egan RA, Fraunfelder FW. Viagra and anterior ischemic optic neuropathy. Arch Ophthalmol 2005;123:709-10.
13. Bollinger K, Lee MS. Recurrent visual field defect and ischemic optic neuropathy associated with tadalafil rechallenge. Arch Ophthalmol 2005;123:400-1.
14. McGwin G, Vaphiades MS, Hall TA, et al. Non-arteritic anterior ischaemic optic neuropathy and the treatment of erectile dysfunction. Br J Ophthalmol 2006;90:154-7.
15. Margo CE, Dustin DF. Ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors. Am J Ophthalmol 2007;143:538-9.
16. Hayreh SS, Zimmerman MB, Podhajsky P, et al. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994;118:766-80.
17. Hayreh SS, Podhasjky P, Zimmerman B. Nonarteritic anterior ischemic optic neuropathy: time or onset of visual loss. Am J Ophthalmol 1997;124:641-7.
18. Hayreh SS. Erectile dysfunction drugs and non-arteritic anterior ischemic optic neuropathy: is there a cause and effect relationship? J Neuroophthalmol 2005;15:9-13.
19. Grunwald JE, Siu KK, Jacob SS, et al. Effect of sildenafil citrate (Viagra) on the ocular circulation. Am J Ophthalmol 2001;131:751-5.
20. Stephens MDB. Detection of new adverse drug reactions, third edition. Basingstoke: Macmillan Press, 1992.
21. Kessler DA. Introducing MEDWatch: a new approach to reporting medication and device adverse events and product problems. JAMA 1993;269:2765-8.
22. Anon. Rhode Island physicians' recognition and reporting of adverse drug reactions. R I Med J 1987;70:311-16.
23. Anon. AIDE Memoir: Drug safety pharmacovigilence quality assurance and safety: medicines essential drugs and medicines policy. Geneva: World Health Organisation.
24. Strom BL. How the US drug safety system should be changed. JAMA 2006;295:2072-5.
25. Spence MM, Teleki SS, Cheetham TC, et al. Direct-to-consumer advertising of COX-2 inhibitors: effect on appropriateness of prescribing. Med Care Res Rev 2005;62:544-59.
26. Food and Drug Administration. FDA updates labeling for Viagra, Cialis, and Levitra for rare post-marketing reports of eye problems (www.fda.gov/bbs/ topics/NEWS/2005/NEW01201.html) 8 July, 2005.
27. Henessy S, Strom BL. PDUFA reauthorization - drug safety's golden moment of opportunity? N Engl J Med 2007;356:17.
28. Pear R. Senate approves tighter policing of drug makers. New York Times 2007 May 10.
29. Peter NM, Singh MV, Fox MV. Taladafil-associated anterior ischaemic optic neuropathy. Eye 2005;19:715-17.
30. Pomeranz HD, Bhavasar AR. Nonarteritic ischemic optic neuropathy developing soon after use of sildenafil (Viagra): a report of seven new cases. J Neuroophthalmol 2005;25:9-13.
31. Pomeranz HD, Smith KH, Hart WM, et al. Sildenafil- associated nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2002;109:584-7.
32. Egan RA, Pomeranz HD. Sildenafil (Viagra) associated anterior ischemic optic neuropathy. Arch Ophthalmol 2000;118:291-2.
33. Cunningham AV, Smith KH. Anterior ischemic optic neuropathy associated with Viagra. J Neuroophthalmol 2001;21:22-5.
34. Dheer S, Rekhi GS, Merlyn S. Sidenafil associated anterior ischemic optic neuropathy. J Assoc Physicians India 2002;50:265.
35. Bosnier A, Pambakian N, Sharkir SA. A case of nonarteritic anterior ischemic optic neuropathy in a male patient taking sildenafil. Int J Pharmacol Ther 2002;40:422-3.
36. Gruhn N, Fledeliurs HC. Unilateral optic neuropathy associated with sildenafil intake. Acta Ophth Scand 2005;1004:131-2.
37. Sinha S, Pathak-Ray V, Ahluvalia H, et al. Viagra or what? Eye 2004;18:446-8.
38. Escaravage GK, Wright JD, Givre SJ. Tadalafil associated with anterior ischemic optic neuropathy. Arch Ophthalmol 2005;123:399- 400.